SCHEMBL16634655

SCHEMBL16634655

Nc1ccccc1Nc1ccc(C(=O)O)cc1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 8/20 0.59
KDM4E B2RXH2 6/20 0.59
MAPT P10636 5/20 0.59
ALDH1A1 P00352 4/20 0.59
HSD17B10 Q99714 3/20 0.59
THRB P10828 3/20 0.59
HPGD P15428 3/20 0.59
SMN1; SMN2 Q16637 2/20 0.58
RAB9A P51151 2/20 0.58
GFER P55789 4/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
MAPK13 O15264 2/20 0.51
MAPK12 P53778 2/20 0.51
MAPK11 Q15759 2/20 0.51
MAPK14 Q16539 2/20 0.51
HDAC1 Q13547 3/20 0.49
HDAC3 O15379 2/20 0.49
HDAC2 Q92769 2/20 0.49
MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27498159 0.88 MAPK13 (0.64) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL16634723 0.79 MAP2K1 (0.54) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL16634860 0.77 HCAR3 (0.63) GAAMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL16634858 0.77 HCAR3 (0.63) GAAMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL29581577 0.77 ALDH1A1 (0.47) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL3606443 0.77 ALDH1A1 (0.47) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL18640986 0.77 GAA (0.69) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL30522830 0.77 GAA (0.69) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL16634589 0.76 MAPK13 (0.78) GAAKDM4EMAPTALDH1A1HSD17B10
SCHEMBL2342942 0.74 GAA (1.00) GAAKDM4EMAPTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015052675-A1 SUBSTITUTED DIHYDRO-BENZIMIDAZOLE COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-16 WO disclosed